|
High SGPC pairs, prostate |
|||||
| Affy HGU95 ID |
Gene symbol |
KEGG ID |
Pathway description |
SGPC |
p |
|
|
|||||
| 39637_at |
SLC26A2 |
00300 |
Lysine biosynthesis |
0.928 |
<1e-04 |
| 39799_at |
FABP5 |
00300 |
Lysine biosynthesis |
0.829 |
<1e-04 |
| 39794_at |
USP8 |
00300 |
Lysine biosynthesis |
0.824 |
<1e-04 |
| 40773_at |
MYL5 |
00300 |
Lysine biosynthesis |
0.82 |
<1e-04 |
| 40027_at |
ATP5S |
00300 |
Lysine biosynthesis |
0.814 |
1e-04 |
| 32001_s_at |
PCSK6 |
04742 |
Taste transduction |
0.807 |
<1e-04 |
| 32001_s_at |
PCSK6 |
00600 |
Sphingolipid metabolism |
0.799 |
<1e-04 |
| 32001_s_at |
PCSK6 |
05110 |
Cholera – Infection |
0.798 |
1e-04 |
| 41275_at |
E2F5 |
00300 |
Lysine biosynthesis |
0.798 |
3e-04 |
| 32001_s_at |
PCSK6 |
00604 |
Glycosphingolipid biosynthesis – ganglioseries |
0.786 |
<1e-04 |
| 32001_s_at |
PCSK6 |
00061 |
Fatty acid biosynthesis |
0.771 |
<1e-04 |
| 32001_s_at |
PCSK6 |
00290 |
Valine, leucine and isoleucine biosynthesis |
0.771 |
<1e-04 |
| 39945_at |
FAP |
00300 |
Lysine biosynthesis |
0.768 |
6e-04 |
| 32001_s_at |
PCSK6 |
03060 |
Protein export |
0.765 |
<1e-04 |
| 38571_at |
FGFR1OP |
04740 |
Olfactory transduction |
0.76 |
<1e-04 |
| 32001_s_at |
PCSK6 |
00190 |
Oxidative phosphorylation |
0.751 |
<1e-04 |
| 38571_at |
FGFR1OP |
00440 |
Aminophosphonate metabolism |
0.749 |
<1e-04 |
| 40176_at |
TRIM27 |
00625 |
Tetrachloroethene degradation |
0.742 |
<1e-04 |
| 38571_at |
FGFR1OP |
04630 |
Jak-STAT signaling pathway |
0.739 |
<1e-04 |
| 38571_at |
FGFR1OP |
04020 |
Calcium signaling pathway |
0.737 |
<1e-04 |
| 38571_at |
FGFR1OP |
00150 |
Androgen and estrogen metabolism |
0.734 |
<1e-04 |
| 38571_at |
FGFR1OP |
04930 |
Type II diabetes mellitus |
0.733 |
<1e-04 |
| 32001_s_at |
PCSK6 |
00930 |
Caprolactam degradation |
0.732 |
1e-04 |
| 38571_at |
FGFR1OP |
04340 |
Hedgehog signaling pathway |
0.73 |
3e-04 |
| 38571_at |
FGFR1OP |
00860 |
Porphyrin and chlorophyll metabolism |
0.728 |
2e-04 |
| 32001_s_at |
PCSK6 |
00903 |
Limonene and pinene degradation |
0.728 |
<1e-04 |
| 38571_at |
FGFR1OP |
04650 |
Natural killer cell mediated cytotoxicity |
0.724 |
2e-04 |
| 38571_at |
FGFR1OP |
04810 |
Regulation of actin cytoskeleton |
0.721 |
1e-04 |
| 38571_at |
FGFR1OP |
01510 |
Neurodegenerative Disorders |
0.721 |
<1e-04 |
| 40925_at |
C7orf44 |
00300 |
Lysine biosynthesis |
0.72 |
1e-04 |
| 38571_at |
FGFR1OP |
04660 |
T cell receptor signaling pathway |
0.719 |
<1e-04 |
| 861_g_at |
MSH2 |
03020 |
RNA polymerase |
0.713 |
<1e-04 |
| 38571_at |
FGFR1OP |
00903 |
Limonene and pinene degradation |
0.712 |
<1e-04 |
| 38571_at |
FGFR1OP |
00290 |
Valine, leucine and isoleucine biosynthesis |
0.711 |
2e-04 |
| 38571_at |
FGFR1OP |
04920 |
Adipocytokine signaling pathway |
0.71 |
<1e-04 |
| 38571_at |
FGFR1OP |
00930 |
Caprolactam degradation |
0.708 |
0.0013 |
| 32001_s_at |
PCSK6 |
00471 |
D-Glutamine and D-glutamate metabolism |
0.707 |
<1e-04 |
| 38571_at |
FGFR1OP |
00140 |
C21-Steroid hormone metabolism |
0.706 |
1e-04 |
| 38571_at |
FGFR1OP |
00562 |
Inositol phosphate metabolism |
0.704 |
<1e-04 |
| 38571_at |
FGFR1OP |
00604 |
Glycosphingolipid biosynthesis – ganglioseries |
0.702 |
7e-04 |
|
High-ranking gene-pathway pairs in prostate data, sorted by descending SGPC. Affymetrix ID, gene symbol, KEGG pathway ID, and pathway description are given, along with the GPC scores; p values are based on a permutation test with 104 resamplings. | |||||
Braun et al. BMC Bioinformatics 2008 9:488 doi:10.1186/1471-2105-9-488 |
|||||